Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,690 | -8,377 | -5,361 | -3,277 | -944 |
| Depreciation Amortization | 92 | 505 | 291 | 195 | 114 |
| Other Working Capital | -116 | -615 | -579 | -385 | -19 |
| Other Operating Activity | 820 | 5,501 | 3,250 | 2,033 | 310 |
| Operating Cash Flow | $-894 | $-2,986 | $-2,399 | $-1,434 | $-540 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -680 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 727 | -1,209 | -1,179 | -666 | 0 |
| Investing Cash Flow | $47 | $-1,209 | $-1,179 | $-666 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 889 | 159 | 9 | N/A |
| Debt Repayment | -102 | -427 | -277 | N/A | 46 |
| Common Stock Issued | 102 | 4,297 | 3,769 | 2,450 | 412 |
| Other Financing Activity | -342 | -120 | -90 | -103 | -29 |
| Financing Cash Flow | $-342 | $4,638 | $3,560 | $2,356 | $429 |
| Exchange Rate Effect | 3 | 20 | 8 | -44 | 7 |
| Beginning Cash Position | 1,327 | 864 | 864 | 864 | 864 |
| End Cash Position | 140 | 1,327 | 854 | 1,076 | 760 |
| Net Cash Flow | $-1,187 | $463 | $-10 | $213 | $-104 |
| Free Cash Flow | |||||
| Operating Cash Flow | -894 | -2,986 | -2,399 | -1,434 | -540 |
| Free Cash Flow | -894 | -2,986 | -2,399 | -1,434 | -540 |